Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of memantine and methylphenidate in the treatment of children with ADHD
IRCT201205157462N7Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- May 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of memantine and methylphenidate in attention deficit hyperactivity disorder (ADHD) (2 arms), sponsored by Tehran University of Medical Sciences. Started May 2012; status: completed.
02
Drugs
memantinemethylphenidate
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on IRCT201205157462N7.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201205157462N7.